Home » Topics » BioWorld Science

BioWorld Science
RSS

China's NMPA approves IND for phase I/II study of BBM-H901

Aug. 11, 2021

Recombinant human NAGLU coexpressing S1S3 phosphotransferase developed for Sanfilippo B syndrome

Aug. 11, 2021

Goldfinch Bio initiates dosing in extension study of GFB-887 for patients with FSGS

Aug. 11, 2021

Rezolute initiates phase Ib study of RZ-402 for DME

Aug. 11, 2021

Skye completes IND-enabling genotoxicity studies for THCVHS

Aug. 11, 2021

Kaleido and COPD Foundation collaborate to advance development of KB-109

Aug. 11, 2021

Anti-PRNP monoclonal antibody decreases tau pathology in mouse Alzheimer's disease model

Aug. 11, 2021

Positive interim data presented from phase I study of FTX-6058

Aug. 11, 2021

aTyr expands its research collaboration with Ohio State University

Aug. 11, 2021

Beta Pharma synthesizes new FGFR inhibitors

Aug. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...